Fasting-mimicking diet to improve prostate cancer and metabolism
Part of Cancer, Hormones & metabolism clinical trials.
This trial tests whether an intermittent, fasting-like diet can help control metastatic prostate cancer and improve metabolic health in men on hormone therapy. Participants follow a specific diet plan and are monitored by the study team.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have biopsy- or scan-confirmed metastatic prostate cancer that still responds to lowering testosterone (castrate sensitive)
- You are starting (or recently started) first-line stronger hormone treatment within 30 days, such as abiraterone, apalutamide, enzalutamide, or darolutamide
- You can read, write, and understand English or Spanish and can talk by phone with the study dietitian
- You have no known allergy to ingredients listed on the study’s ingredient list
- You are not underweight (BMI must be 20 or higher)
- You are not trying to lose weight, using weight-loss medications, or planning weight-loss surgery soon
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study combines a special periodic diet that mimics fasting with the standard immunotherapy drug pembrolizumab (Keytruda) for people with advanced non-small cell lung cancer. The goal is to see if the diet can help the immunotherapy work better.
This study tests whether a special low-calorie diet that mimics fasting can help people with multiple sclerosis feel better and reduce inflammation. Over several months, participants will follow this diet in cycles and be monitored with MRI scans and blood tests.
This trial tests whether a special low-calorie diet that mimics fasting can make chemotherapy more effective for people with hormone-receptor-positive breast cancer. If you qualify, you would follow this diet for a few days before and during your chemo cycles.
This trial tests whether a special low-calorie 'fasting-mimicking' diet can reduce side effects from common immunotherapy drugs for advanced cancer. If you're on a PD-1, PD-L1, or CTLA-4 inhibitor, this diet might help you feel better during treatment.
This study tests if a special diet that mimics fasting can help reduce side effects from hormone therapy (aromatase inhibitors) in women with breast cancer. The diet is a low-calorie meal plan designed to lower cholesterol and improve well-being.
This study tests whether a special low-calorie diet that mimics fasting can help reduce risk factors for aging and age-related diseases. It is for healthy adults aged 30 to 65 who are willing to follow this diet for several days each month.
Hear when a new Prostate Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.